About the Authors
- Rajneesh Malhotra
-
* E-mail: rajneesh.malhotra@astrazeneca.com
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Nisha Kurian
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Xiao-Hong Zhou
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Fanyi Jiang
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Susan Monkley
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Amy DeMicco
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Ib G. Clausen
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Göran Delgren
-
Affiliation Thoraxtransplantation, Transplantationscentrum, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden
- Goran Edenro
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Miika J. Ahdesmäki
-
Affiliation AstraZeneca, Oncology iMed, AstraZeneca, Cambridge, CB2 0RE, United Kingdom
- Maryam Clausen
-
Affiliation AstraZeneca, Discovery Sciences, Pepparedsleden 1, Mölndal, Sweden
- Lisa Öberg
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Elisabeth Israelsson
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Graham Belfield
-
Affiliation AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden
- Outi Vaarala
-
Affiliations AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, Mölndal, Sweden, Clinicum, University of Helsinki, Helsinki, Finland
Competing Interests
All of the authors with the exception of Göran Delgren are employed by the commercial company "AstraZeneca". There are no patents, products in development or marketed products to declare. We declare our affiliation to AstraZeneca does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceptualization: IGC NK X-HZ MA MC GB OV RM SM LÖ EI. Data curation: IGC MA SM EI. Formal analysis: IGC MA GB SM LÖ EI. Investigation: IGC NK X-HZ FJ GE MA MC GB SM AD LÖ EI. Methodology: IGC NK X-HZ FJ GD GE MA MC GB OV RM SM LÖ AD. Project administration: GB OV RM SM. Resources: IGC NK X-HZ FJ GD GE MA MC GB SM AD LÖ EI. Software: IGC SM LÖ EI. Supervision: RM GB. Validation: IGC NK X-HZ FJ GE MA MC GB SM LÖ. Visualization: IGC NK MA GB OV RM SM AD LÖ EI. Writing – original draft: IGC NK X-HZ GE MA MC RM GB SM LÖ. Writing – review & editing: IGC NK GB OV RM.